Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Volume: 369, Issue: 18, Pages: 1691 - 1703
Published: Oct 30, 2013
Abstract
BACKGROUND In a phase 1–2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clinical activity was noted in patients with advanced pancreatic cancer. We conducted a phase 3 study of the efficacy and safety of the combination versus gemcitabine monotherapy in patients with metastatic pancreatic cancer. METHODS We randomly assigned patients with a Karnofsky performance-status score of 70 or more (on a scale from 0 to...
Paper Details
Title
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Published Date
Oct 30, 2013
Volume
369
Issue
18
Pages
1691 - 1703
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.